.RESEARCH STUDY FEATURE.19 September 2024. Plozasiran minimized triglyceride degrees through 80% and lowered the risk of pancreatitis in clients with persistent chylomicronemia, with or without a genetic diagnosis.
Delivering daily news and insights on every topic, from global events and finance to technology, health, and lifestyle.
.RESEARCH STUDY FEATURE.19 September 2024. Plozasiran minimized triglyceride degrees through 80% and lowered the risk of pancreatitis in clients with persistent chylomicronemia, with or without a genetic diagnosis.